Skip header and navigation

Narrow By

   MORE

2 records – page 1 of 1.

Inflammatory Bowel Disease : A Point of Care Clinical Guide

https://libcat.nshealth.ca/en/permalink/provcat39181
Daniel J. Stein, Reza Shaker, editors. --Cham: Springer , c2015.
Available Online
View e-Book
Location
Online
This volume provides a unique point-of-care reference for clinicians who care for Inflammatory Bowel Disease patients. Busy clinicians need the best evidence based answers to patient questions at their fingertips at the time questions present themselves. Each chapter is based on responses to common IBD patient questions from IBD experts who answer these questions every day. Through these questions this book guides clinicians through the complicated management of IBD; including disease onset and…
Available Online
View e-Book
Other Authors
Stein, Daniel J
Shaker, Reza
Responsibility
Daniel J. Stein, Reza Shaker, editors
Place of Publication
Cham
Publisher
Springer
Date of Publication
c2015
Physical Description
1 online resource (xvii, 237 p. : 4 illus., 3 illus. in color)
ISBN
9783319140728
9783319140711 (print ed.)
Subjects (MeSH)
Inflammatory Bowel Diseases
Evidence-Based Medicine - methods
Abstract
This volume provides a unique point-of-care reference for clinicians who care for Inflammatory Bowel Disease patients. Busy clinicians need the best evidence based answers to patient questions at their fingertips at the time questions present themselves. Each chapter is based on responses to common IBD patient questions from IBD experts who answer these questions every day. Through these questions this book guides clinicians through the complicated management of IBD; including disease onset and natural history, therapy initiation, medications complications, therapeutic monitoring, surgery and accurate disease monitoring. Lastly, the book addresses special situations, such as alternative therapies, pregnancy, and fertility. Written by experts in the field, Inflammatory Bowel Disease: A Point of Care Clinical Guide is a valuable reference for gastroenterologists, gastroenterology fellows, mid-level providers and any clinician involved in the care of IBD patients.
Contents
[publisher supplied] 1. Why did this happen to me?: Epidemiology, Genetics, Environment, and Etiology of IBD -- 2. So what is Crohn's disease and Ulcerative colitis?: Making the proper diagnosis, avoiding IBD mimickers, and identifying factors that distinguish CD from UC -- 3. What happens if I do nothing?: The natural history of IBD, treated and untreated -- 4. Proper staging and management of newly diagnosed Crohn's disease -- 5. Proper staging and management of newly diagnosed Ulcerative colitis -- 6. Monitoring for common side effects and adverse reactions of IBD medications -- 7. Healthcare maintenance in patients with IBD -- 8. Pregnancy and unique women's issues in IBD -- 9. Imaging and IBD -- 10. Perianal Crohn's disease -- 11. Surgical management of Crohn's disease -- 12. Management of severe/fulminant Ulcerative colitis -- 13. Surgical management of Ulcerative colitis -- 14. Post operative management of IBD patients -- 15. Pouchitis -- 16. Ostomies.
Format
e-Book
Location
Online
Less detail

Treatment of Inflammatory Bowel Disease with Biologics

https://libcat.nshealth.ca/en/permalink/provcat42935
edited by Adam S. Cheifetz, Joseph D. Feuerstein. --Cham, Switzerland: Springer , c2018.
Available Online
View e-Book
Location
Online
This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn's disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment …
Available Online
View e-Book
Other Authors
Cheifetz, Adam S.
Feuerstein, Joseph D.
Responsibility
edited by Adam S. Cheifetz, Joseph D. Feuerstein
Place of Publication
Cham, Switzerland
Publisher
Springer
Date of Publication
c2018
Physical Description
1 online resource (xi, 335 p.) : 22 illus., 19 illus. in color
ISBN
9783319602769
9783319602752 (print ed.)
9783319602776 (print ed.)
9783319868233 (print ed.)
Subjects (MeSH)
Anti-Inflammatory Agents - therapeutic use
Biological Products - therapeutic use
Inflammatory Bowel Diseases - drug therapy
Specialty
Biological Therapy
Gastroenterology
Abstract
This book is a concise yet comprehensive overview of the use of biologics for the treatment of Crohn's disease and ulcerative colitis. The volume details how best to utilize these medications in order to optimize their efficacy and safety, as well as how to understand, recognize, and treat complications that may arise from using biologics to treat IBD. The text also focuses on new data, novel biologics, and biosimilars of this rapidly expanding field. Written by experts in the field, Treatment of Inflammatory Bowel Disease with Biologics is a valuable resource for gastroenterologists, allied health professionals, fellows, and trainees who treat patients with inflammatory bowel disease.
Contents
Mechanism of Action and Pharmacokinetics of Biologics -- Anti-tumor Necrosis Factor Agents in Ulcerative Colitis -- Anti-tumor Necrosis Factor Agents in Crohn's Disease -- Anti-TNF Therapy for Treatment of Extraintestinal Manifestations of Inflammatory Bowel Disease -- Use of Biologics in the Postoperative Management of Crohn's Disease -- Biologics in Pregnancy and Breastfeeding -- Concomitant Use of Immunosuppressive Therapy with Tumor Necrosis Factor (TNF) Antagonists in Inflammatory Bowel Disease -- Therapeutic Drug Monitoring of Biologic Agents -- Use of Biologics in Crohn's Disease and Ulcerative Colitis Prior to Surgery and Perioperative Risks -- Cessation of Biologics—Can it be Done? -- Biologic Therapy in Pediatric Inflammatory Bowel Disease -- Infectious Complications of Biologics -- Tumor Necrosis Factor-Alpha Inhibitors and Risks of Malignancy -- Non-infectious and Non-malignant Complications of Biologics -- Biosimilars in Inflammatory Bowel Disease 2017: State of the Science, State of the Art, State of the Finances -- Anti-Integrin Agents in IBD: Efficacy and Risk of Complications -- Novel Agents in Inflammatory Bowel Disease -- Quality, Safety, and Practical Considerations of Using Biologic Therapies.
Format
e-Book
Location
Online
Less detail